Aryzta AG
SWB:YZA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aryzta AG
SWB:YZA
|
CH |
|
K
|
Kailera Therapeutics Inc
NASDAQ:KLRA
|
US |
|
Oruka Therapeutics Inc
F:HQ1
|
US |
|
S
|
Silvercrest Metals Inc
SWB:S0C
|
CA |
Wall St Price Targets
YZA Price Targets Summary
Aryzta AG
According to Wall Street analysts, the average 1-year price target for YZA is 119.63 EUR with a low forecast of 99.22 EUR and a high forecast of 146 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YZA's stock price target?
Price Target
119.63
EUR
According to Wall Street analysts, the average 1-year price target for YZA is 119.63 EUR with a low forecast of 99.22 EUR and a high forecast of 146 EUR.
What is the Revenue forecast for Aryzta AG?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Aryzta AG?
Projected CAGR
-11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -4%. The projected CAGR for the next 3 years is -11%.
What is the Operating Income forecast for Aryzta AG?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been -5%. The projected CAGR for the next 3 years is 8%.
What is the Pre-Tax Income forecast for Aryzta AG?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Aryzta AG?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 3 years is 11%.
